ALX ONCOLOGY HOLDINGS INCALXO
ASignal's systematic analysis rates ALXO as Bearish.
Reflects the latest available analysis · analyzed Oct 11, 2026
The case on ALXO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.08x)
- High liquidity with current ratio of 9.71x
- RSI near oversold level (27.96), potential reversal signal
- Negative MACD histogram indicating weakening momentum
- Declining price trend (negative price momentum)
- Negative return on equity (-80.65%)
- Negative operating and free cash flow
- No news coverage or Reddit sentiment data available
See the full verdict on ALXO
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ALXO
Most investors never get a second opinion, let alone several. ASignal runs ALXO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.